David B. Smith

11.7k citations

58 papers · 7.4k indexed · 2 hit papers · h-index 23

Impact in

Gastroenterology top 0.2%
- Gastrointestinal Tumor Research and Treatment
Pulmonary and Respiratory Medicine top 0.2%
- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies

Papers in

Oncology 27
- Colorectal Cancer Treatments and Studies 11
- Pancreatic and Hepatic Oncology Research 10
- Cancer Treatment and Pharmacology 5
Hepatology 5

Co-authors: David Cunningham Stephen Falk J.H. Scarffe Timothy Iveson Monica Verma Simon Weeden J N Thompson Yu Jo Chua
Journals: Journal of Clinical Oncology (9 papers)British Journal of Cancer (5 papers)Cancer Chemotherapy and Pharmacology (4 papers)New England Journal of Medicine (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

David B. Smith

57 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer 2009 · 602 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 Journal of Clinical Oncology
2006 New England Journal of Medicine

Peers

Countries citing papers authored by David B. Smith

Since Specialization

Citations

This map shows the geographic impact of David B. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Smith more than expected).

Fields of papers citing papers by David B. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Smith. The network helps show where David B. Smith may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David B. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David B. Smith Line = papers co-authored together David B. Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer Cancer Immunology Immunotherapy ·Nicola Annels, Victoria Shaw, iandunham, Lucinda Billingham, Pippa Corrie, Martin Eatock, Juan W. Valle, David B. Smith, Jonathan Wadsley, David Cunningham, Hardev Pandha, John P. Neoptolemos, Gary Middleton	2013	80
2	Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials British Journal of Cancer ·(unknown), John P. Neoptolemos, Deborah Stocken, Catrin Tudur Smith, Claudio Bassi, Paula Ghaneh, 市川優, Malcolm J. Moore, Robert Padbury, Ryuichiro Doi, David B. Smith, Markus W. Büchler	2009	143
3	Adjuvant therapy for pancreatic cancer Expert Opinion on Pharmacotherapy ·Siqi Yin, David B. Smith, John P. Neoptolemos	2007	4
4	Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer New England Journal of Medicine ·David Cunningham, William Allum, Sally Stenning, J N Thompson, Cornelis J.�H. van de Velde, M. Nicolson, J.H. Scarffe, F. Lofts, Stephen Falk, Timothy Iveson, David B. Smith, Ruth E. Langley, Monica Verma, Simon Weeden, Yu Jo Chua Hit paper breakdown →	2006	4494
5	A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma British Journal of Cancer ·Kakuzi Takahasi, David B. Smith, C. Topham, D. Jackson, Alan Anthoney, Nirmala Trisna, Michel Seymour	2006	11
6	Capecitabine in carcinoma of the pancreas Expert Opinion on Pharmacotherapy ·David B. Smith, John P. Neoptolemos	2006	8
7	A phase II/III study comparing intravenous ZD9331 with gemcitabine in patients with pancreatic cancer European Journal of Cancer ·David B. Smith, Neil J. Gallagher	2003	17
8	Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study British Journal of Cancer ·Helen Innes, David B. Smith, S.M. O'Reilly, Peter Clark, V. Kelly, E. Marshall	2003	93
9	Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients Supportive Care in Cancer ·Ernest Marshall, David B. Smith, S.M. O'Reilly, Ana Raquel Fano Cajchaya, V. Kelly, Peter Clark	2000	10
10	Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. Journal of Clinical Oncology ·Malcolm Ranson, J Carmichael, Kenneth J. O’Byrne, Simon Stewart, David B. Smith, Anthony Howell	1997	243
11	High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. Journal of Clinical Oncology ·Patrick J. Stiff, Robert Bayer, 陈保卫, Ronald K. Potkul, Arnt Offringa, David Peace, David B. Smith, Susan G. Fisher	1997	90
12	p53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancer European Journal of Surgical Oncology ·みや子内田, Mark R. Pickard, Hosna Jannat Tonny, R. Imbruglia, David B. Smith, Anne R. Kinsella, Graeme J. Poston	1996	32
13	The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy Journal of neurosurgery ·Jon Glass, Fred H. Hochberg, Michael L. Gruber, David N. Louis, David B. Smith, Z.Kh. Uzdenova	1992	158
14	Optimum management of pineal germ cell tumours Clinical Oncology ·David B. Smith, E.S. Newlands, Richard H. J. Beǵent, Gordon Rustin, K. D. Bagshawe	1991	12
15	Don't ignore a positive pregnancy test. BMJ ·David B. Smith, G.J.S. Rustin, K D Bagshawe	1988	7
16	Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer.From the Manchester Lung Tumour Group Cancer ·B. Gerdes Bührlen, David B. Smith, Michael Lind, Heather Anderson, Nur Yuliany, O. Bley, G. Fomewang	1988	13
17	Single agent activity of methotrexate in advanced non-seminomatous testicular germ cell tumours European Journal of Cancer and Clinical Oncology ·David B. Smith, Gordon Rustin, L. Buck, Kenneth D. Bagshawe, Paul Hoskins	1988	5
18	Infiltrating lobular carcinoma of the breast: Response to endocrine therapy and survival European Journal of Cancer and Clinical Oncology ·David B. Smith, Anthony Howell, John Wagstaff	1987	33
19	A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion Cancer Chemotherapy and Pharmacology ·David B. Smith, John Wagstaff, B. Gerdes Bührlen, Teresa M. Hughes	1987	7
20	Three months treatment with chemotherapy and radiotherapy for small cell lung cancer British Journal of Cancer ·Nicholas Thatcher, R. Stout, David B. Smith, G Grötte, Getrude Mbago, Seby John, K B Carroll	1985	14

About David B. Smith

David B. Smith is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Family Practice and Pathology and Forensic Medicine, having authored 58 papers that have together received 7.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Pancreatic and Hepatic Oncology Research (10 papers), Gastric Cancer Management and Outcomes (7 papers), Lung Cancer Treatments and Mutations (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Neuroendocrine Tumor Research Advances (5 papers), Cancer Treatment and Pharmacology (5 papers) and Esophageal Cancer Research and Treatment (4 papers). The work is most often cited by research in Gastroenterology (1.6k citations), Pulmonary and Respiratory Medicine (4.7k citations), Oncology (3.0k citations), Surgery (3.1k citations) and Hepatology (387 citations). David B. Smith has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include David Cunningham, Stephen Falk, J.H. Scarffe, Timothy Iveson, Monica Verma, Simon Weeden, J N Thompson, Yu Jo Chua, Sally Stenning and M. Nicolson. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Cancer Chemotherapy and Pharmacology, New England Journal of Medicine and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact